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http://www.biomedcentral.com/1472-6963/14/573RESEARCH ARTICLE Open AccessHealth state descriptions to elicit stroke values:
do they reflect patient experience of stroke?
Joanne Gray1*, Mabel L S Lie3, Madeleine J Murtagh5, Gary A Ford4, Peter McMeekin2 and Richard G Thomson2Abstract
Background: To explore whether stroke health state descriptions used in preference elicitation studies reflect patients’
experiences by comparing published descriptions with qualitative studies exploring patients’ lived experience.
Methods: Two literature reviews were conducted: on stroke health state descriptions used in direct preference elicitation
studies and the qualitative literature on patients’ stroke experience. Content and comparative thematic analysis was used
to identify characteristics of stroke experience in both types of study which were further mapped onto health related
quality of life (HRQOL) domains relevant to stroke. Two authors reviewed the coded text, categories and domains.
Results: We included 35 studies: seven direct preference elicitation studies and 28 qualitative studies on patients’
experience. Fifteen coded categories were identified in the published health state descriptions and 29 in the qualitative
studies. When mapped onto domains related to HRQOL, qualitative studies included a wider range of categories in every
domain that were relevant to the patients’ experience than health state descriptions.
Conclusions: Variation exists in the content of health state descriptions for all levels of stroke severity, most critically with
a major disjuncture between the content of descriptions and how stroke is experienced by patients. There is no
systematic method for constructing the content/scope of health state descriptions for stroke, and the patient perspective
is not incorporated, producing descriptions with major deficits in reflecting the lived experience of stroke, and raising
serious questions about the values derived from such descriptions and conclusions based on these values.
Keywords: Cerebrovascular disease/stroke, Outcome research, Quality of life, Preference elicitation, Patient experienceBackground
Health related quality-of-life assessment methods are
increasingly used to develop indices that can support
health economic evaluation of stroke care. Utility (or
preference-based) measures, typically reporting on a
single 0 to 1 scale, based upon decision and utility
theories, are designed to elicit the value people place
on a particular health state. Such preference-based
approaches integrate different aspects of health into a
single index, usually anchored by a value of ‘1.00’ for full
health and ‘0’ for death. These measures are increasingly
important since they are used to actively inform both
health policy and individual decision-making. At a
population level, they support resource allocation
decisions with their use in health technology assessment
and economic evaluation that lead to the production of* Correspondence: Joanne3.Gray@northumbria.ac.uk
1School of Health, Community and Education Studies, Northumbria
University, Coach Lane, Benton, Newcastle upon Tyne NE7 7XA, UK
Full list of author information is available at the end of the article
© 2014 Gray et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
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unless otherwise stated.guidance to health services regarding the use of
health interventions e.g. in England and Wales guidelines
are produced by National Institute for Health and Care
Excellence (NICE) [1]. Furthermore, these measures are
adopted in guideline production in a number of different
countries including Australia [2] Canada [3] and the United
States [4]. They have also been used to support decision
making at an individual level, e.g. by incorporating decision
analytical models in clinical decision support systems and
patient decision aids [5,6].
Two approaches to utility elicitation exist - indirect
and direct. In indirect elicitation patients complete a
questionnaire, such as the EQ-5D, which is mapped onto
utility scores previously developed. Indirect methods are
less time consuming for respondents, but lack content
coverage and are often insensitive to change [7-9]. Direct
methods are more complex and time consuming, but it
is suggested that they may be more reliable, valid and
responsive [10]. They require health state descriptionsd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(examples are shown in Table 1), and derive a value by
taking respondents through a valuation exercise, such as
visual analogue scale (VAS) standard gamble (SG) or
time trade off (TTO) [11,12]. These approaches differ in
the way they are undertaken, but all seek to derive a
value between 0 and 1 for the relevant health state by
taking people through a guided exercise.
Equally, it is increasingly recognised that health services
and policy need to reflect the patient and public perspectiveTable 1 Examples of health state descriptions
Author Health state description
Robinson et al.
2001 [13]
Mild stroke
• Your arm and leg are a little weak on one side
• Your speech is a little slurred but people understand you
• You may be unable to perform some of your
usual activities
• You can look after yourself as usual
For the rest of your life
Severe stroke
• One side of your body is totally limp (paralysed)
• Your speech is slurred – it is very hard to
understand you
• You are unable to perform most of your usual
activities
• You cannot look after yourself without help
For the rest of your life
Hallan et al. [14] Minor stroke (Rankin scale: level 2–3)
• Your right arms is limp (paralysed) and your leg
is slightly weakened
• You can think, read and speak clearly
• You have full control of bladder and bowel
• You can walk at normal speed, but with a
slight limp
• You must learn to write with the left arm
• You need some help with feeding, dressing
and other tasks normally requiring both arms
Major stroke (Rankin scale: level 4–5)
• The right side of your body is totally limp
(paralysed)
• You can think clearly
• Your speech is slow and unclear but
understandable
• You have full control of bladder and bowel
• You cannot walk at all so you must use a
wheelchair
• You need some help for feeding, dressing and
transferring
You are totally dependent on help for bathing
You may need to go to a nursing homethrough patient centred and personalised care [15]. This
implies that any such values derived from patients and the
public, and used to support decision-making, should be
valid and reliable, and appropriately reflect lived patient
experience.
It is widely reported that direct utility estimates vary
considerably, which might reflect the method used or
the way the health states are described [16]. Specifically
for stroke, variations in estimates resulting from direct
preference elicitation have previously been explained by
a number of factors. First, the choice of study population;
for example, healthy participants assign lower utilities
than patients who have experienced stroke [11,17].
Second, the method of elicitation, with standard gamble
derived scores being generally higher than those derived
from time trade off studies, which in turn are higher than
those derived from visual analogue scales [16,18]. Third,
the bounds of the scale, typically 0–1, may be defined
differently: the upper bound defined as perfect health
yields lower utility scores than if defined as the absence of
the condition of interest, which is no guarantee that health
is perfect [19].
Variations in health state descriptions content may
also explain differences. The level of detail in health
state descriptions can affect utility scores; longer, more
comprehensive, descriptions (although appearing to have
more face validity), can overload respondents’ cognitive
capacity so that they latch onto a few key phrases and
ignore the rest [20]. Naming or labelling a condition may
have an impact [20-23] with a recent study recommending
avoiding condition labels in health state descriptions to
ensure that values are not affected by prior knowledge or
preconceptions of the condition that may distort the
health state being valued [10]. Furthermore, the wording
may also cause variation in values if not presented in a
balanced manner (framing bias), with both positive and
negative effects described; explicit inclusion of negative
aspects of stroke elicit lower values [24,25].
Despite this, little attention has been given to the
appropriateness of health state descriptions. If they
don’t adequately reflect the reality of the health states they
seek to measure, decisions based on these derived
estimates may be compromised. Hence, at the very least,
descriptions should reflect the reality of living with a
stroke. Therefore, we set out to determine whether
published stroke health state descriptions used in
value elicitation studies truly reflect patients’ experiences
of stroke by comparing their content with the results of
qualitative studies exploring patients’ lived experience of
stroke.
Methods
Two literature reviews were conducted: stroke health state
descriptions used in direct preference elicitation studies
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stroke. The former review sought to comprehensively
capture published health state descriptions for stroke
used in preference elicitation studies; the latter, to
capture what is important to patients in their lived
experience of stroke from qualitative studies of patient
perspectives. Both reviews involved the use of search
strategies that included a combination of both subject
headings and relevant key words.
Search strategy for health state descriptions
MEDLINE, CINAHL and PsychInfo were searched (1980
to 2011) using the search terms: stroke, cerebrovascular
accident, cerebral arterial diseases, cerebrovascular disor-
ders, cerebral thrombosis, carotid artery thrombosis, cere-
bral haemorrhage, cerebral hematoma, apoplexy, hemiplegia
and hemiparesis. These terms were combined with
the following terms: utility, quality of life, preference
elicitation, time trade off (TTO), standard gamble (SG),
Quality Adjusted Life years (QALY), stroke preferences,
cost-effectiveness analysis and cost-utility analysis. Reference
lists of all included articles were also searched.
Articles were included if they used appropriate direct
preference elicitation methods, were in English and
included the wording of the health state description.
One reviewer performed initial selection (JG). Two
reviewers (ML and RT) independently assessed studies
for inclusion and extracted data, with disagreement
resolved by discussion.
Search strategy for patients’ experience of stroke
MEDLINE, Embase, ISI Web of Knowledge and PsychINFO
were searched (1997 to 2011) using the search terms: stroke,
experience and qualitative, supplemented by hand searching
reference lists from papers identified in both searches and
related PubMed citations. Studies were included if:
the findings focused on experiences of patients with
stroke; were in English; used accepted qualitative
methods; provided a clear exposition of methods and
data collection; were supported by direct quotations;
and were deemed of sufficient quality. Quality of the
studies was based on criteria established by Mays and
Pope [26]. Articles were scrutinised by two experienced
qualitative researchers (MM, ML) and were included in the
review if they were based on the appropriate application of
established qualitative methods –that data collection,
analysis and sample selection were appropriate to the
explicit or implicit research question(s) - and contributed
to knowledge in the field. Studies that did not provide
sufficient detail of methods or those reporting opinion,
but not providing direct empirical evidence, were rejected.
Articles on the experiences of carers and professionals,
trial participation, and assessments of rehabilitation therap-
ies, information provision, and healthcare and communityservices were excluded. Articles focusing on specific charac-
teristics of stroke experience such as end of life, pain, com-
munication, return to employment or wheelchair use were
excluded to avoid the data being skewed to one particular
aspect of the stroke experience. Results and discussion
sections were extracted for use in content and thematic ana-
lysis. The extracted data were coded as described below.
Content analysis and interpretation
Content analysis [27-29] was used by MLSL to identify the
characteristics of stroke experience included in health state
descriptions and in the results/discussion sections of qualita-
tive studies. Using an inductive approach, text describing
the patient experience was subjected to open-coding and
category creation with the help of NVIVO software [30]. A
comparative analysis was conducted to ensure the distinc-
tions between the categories and the consistency of the con-
tent coded within each of the categories as well as across
the two sets of data sources i.e. preference elicitation studies
and qualitative literature. Qualitative inter-rater checking of
definitions of the categories and the coded text was carried
out by JG and discussed by the research team. Data regard-
ing counts of the number of studies that included each
category was extracted in order to undertake a comparative
analysis of both types of study in terms of these categorised
counts. The categories and counts of study were further
mapped onto four predefined domains of HRQOL that en-
compass relevant areas from the stroke patients’ perspective
as being crucial to quality of life measurement [7,30]: bio-
physical, mood and cognition, prognosis and social domains.
In order to interpret the experience of stroke represented
by the characteristics defined in the content analysis we
also undertook a thematic synthesis of the qualitative
studies [31]. This method includes systematic searching of
the literature, quality assessment (as described above),
extraction of data and thematic analysis of those data,
i.e. familiarisation and coding line by line to develop
descriptive themes. The text of results sections of each
qualitative article formed the data for analysis. The
thematic analysis conducted by MJM was an inductive
process which followed the six stages described by Baun
and Clarke [32]: familiarisation, generation of initial codes,
searching for themes, reviewing themes, defining and
naming themes and reporting the analysis. Here we
term these ‘categories’ for ease of comparison with the
content analysis. Content and thematic analyses of
categories are integrated in the results below. Interpretation
of these themes forms the analytic component of the
analysis and is reported in the discussion.
Results
Health state descriptions
Seven studies that used direct preference elicitations
were included (Table 2) [13,14,17,24,33-35]. Research
Table 2 Summary of preference elicitation studies
Preference
elicitation study
Objective Research subjects Types of stroke
covered by health
state descriptors
Development of health
state descriptions:
information sources
Method of
elicitation
Solomon et al.
1994 [24]
To examine patient
preferences for
different outcomes of
stroke including death
All outpatients referred
to a neuro-diagnostics
laboratory for ultrasound
evaluation of the carotid
artery
Consequences of stroke:
mild, moderate and
severe impairment of
three types of
neurological deficit:
motor, language and
cognitive. Descriptions
for a painless fatal stroke
and perfect health.
Stroke deficit types scaled
in terms of severity
classifications: mild,
moderate and severe
impairment. Scaling
validity of stroke deficit
types: tested by three
neurologists specialized
in stroke care.
Rank and scale
method over a
100 point range:
100 representing
perfect health and
0 representing the
worst possible
health state.
Age, y(mean ± SD ): 73 ± 9
Gender, % female: 45
Country: USA
No reference to how
or why deficit types
were identified
Gage et al.
1996 [33]
To determine how
stroke and stroke
prophylaxis affect
quality of life using
direct preference
elicitation
Patients with atrial
fibrillation, at least
50 years of age, could
read English and who
did not reside in a
convalescent hospital
Mild, moderate and
major stroke
Categorised by
progressively more severe
neurological deficit based
on Modified Rankin Scale
(mild - mRS 1 or 2,
moderate 3 or 4, severe
4 or 5). Utilised van
Hoeyweghen et al. [36]
which recommended that
stroke descriptions of
function cover multiple
domains: fine and gross
motor skills, spoken and
written language are,
and cognitive and
psychosocial function
Time trade-off and
standard gamble
Age, y(mean ± SD ):
70.1 ± 7.3
Gender, % male: 86
Country: USA
Shin et al.
1997 [34]
To determine younger
patients’ perceptions of
quality of life with a
stroke by eliciting
utility values
Younger patients
with arteriovenous
malformations who
are at risk of a stroke or
have experienced one.
Major and minor stroke No information regarding
how stroke severity
classifications were
developed
Standard gamble
Age, y(mean)(range):
37(18–57)
Gender: not reported
Country: Canada
Samsa et al.
1998 [17]
To examine attitudes
toward hypothetical
major stroke
Patients at increased risk
of stroke including those
with and without a
history of cerebrovascular
symptoms but at
increased risk of stroke
due to conditions such
as atrial fibrillation,
hypertension and
vascular heart disease
Major stroke with
and without aphasia
No information regarding
how stroke severity
classifications were
developed
Time trade-off
Age, y(mean): 65
Gender, % male: 52
Country: USA
Hallan et al.
1999 [14]
To elicit valid quality
of life estimates and
the highest acceptable
treatment risk of
different outcomes
after stroke
Healthy people, non
stroke medical patients
and stroke survivors
20–84 years old
Minor and major stroke Classifications for minor
and major stroke based
on Rankin scale 2–3 and
4–5 respectively
Standard gamble,
time trade-off and
direct scaling
Age, y(mean): not
reported
Gender: not reported
Country: Norway
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Table 2 Summary of preference elicitation studies (Continued)
Robinson et al.
2001 [13]
To elicit patient
valuations of health
states relevant to
the assessment of
the prevention of
stroke by warfarin
anticoagulation
therapy
Patients over the
age of 60 years
with atrial
fibrillation
Mild and severe
stroke as well as
hospital managed
warfarin and
major bleed
Adapted from 2 previous
studies
Standard gamble
Age, y(mean)(range):
73(60–87)
Gender, % male: 54
Country: England
Slot and Berge
2009 [35]
To ascertain patients’
preferences for
thrombolytic
treatment for
acute stroke
Elderly people at five
day care centres:
ischaemic stroke
survivors and
age- matched
control subjects
who were at risk
of stroke
Mild, moderately
severe and severe
ischaemic stroke
Based on Modified
Rankin Scale for
mild (mRS =1),
moderately severe
(mRS =3) and
severe (mRS = 5)
stroke
Standard gamble
Age, y(mean ± SD): 78 ± 6
Gender: not reported
Country: Norway
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risk of stroke and healthy people. Health descriptions
ranged from mild/minor, moderate to severe/major
stroke, examples of which are presented in Table 1, with
standard gamble and time trade off the most frequent
methods.
Patients’ experience of stroke
Twenty eight qualitative studies examining post stroke
experience were included [37-64] (Table 3) and were
conducted in the UK (n = 9), the USA (n = 7), Norway
(n = 4), Sweden (n = 4), Canada (n = 3) and Australia
(n = 1). Methods predominantly comprised one-to-one
interviews, with two studies employing focus groups
[37,38]. The theoretical perspectives for analysis included
phenomenology [39-46], grounded theory [37,39,47-49],
narrative analysis [50-52] and discourse analysis [53].
Participants were predominantly over 60 and Caucasian,
although US studies included Hispanic and African
Americans. Two studies [49,51] included a small number
of Bangladeshis and African Caribbeans. Specific sub-
populations were targeted in seven studies: elderly
non-institutionalised women [54], women in a rural
setting [41], patients in the community [55], working
class men [43], young women stroke survivors [56]
and US war veterans [47,52].
Content analysis
Fifteen coded categories were identified in the preference
elicitation studies (Table 4). The categories included
varied across the studies, with only paralysis and depend-
ence included in all. Only three studies made reference
to continuing or worsening disability [13,14,17]. Toileting[14,35], care arrangements [24,14] and mortality [17,24]
were identified in only two studies. Solomon et al.
[24] included the most categories within their descriptions
and this was the only study to include pain and receptive
problems. The following is an example of coded text
under the category “Receptive problems”:
“You suffer a stroke that takes away your ability to
understand language. You no longer understand anything
being said to you” [24]
The sparest thematic content was found in Samsa et al.
[17], although this only included major stroke, described as:
“a stroke that leaves an arm, a leg, and one side of
your body paralyzed, and leaves you unable to take care
for yourself. Anyone who has a major stroke will stay in
this state until death”.
In addition and in order to help assess the relative
impact of aphasia on preferences associated with major
stroke, approximately 50% of the interviewees were
randomly assigned to include the inability to speak in the
description of the sequelae of a major stroke.
Information sources used to develop health state descrip-
tions varied, but there was no reference to stroke patients’
perspectives; no studies included primary research with
patients to ascertain them. Three studies [25,26,65] used an
existing functional outcome scale – the Modified Rankin
Scale (mRS) – which ranks levels of disability [50] to inform
descriptions, with only one [25] citing further evidence [51]
to support domains of function included. The scaling
validity of the severity classifications for one study [30] were
tested by neurologists specialising in stroke care. Two stud-
ies [28,29] made no reference to how the descriptions were
developed. One study [27] suggested that the descriptions
were adapted from a previous study [25].
Table 3 Summary of qualitative studies
Author & date Title of article Country Sample characteristics Details
1 Nilsson I, Jansson L,
Norberg A. 1997 [45]
To meet with stroke: Patients’
experiences and aspects seen
through a screen of crises.
Sweden n =10 Narrative interviews one month
and two months after discharge.
Phenomenological hermeneutic
analysis.
9 male, 1 female
Age: 53-81
2 Pound P, Gompertz P,
Ebrahim S. 1998 [49]
Illness in the context of older
age: The case of stroke.
UK n =40 In-depth semi-structured interviews.
Grounded theory and constant
comparison.21 male, 19 female
Age: 40-87
Predominantly
working-class elderly
3 Pound P, Gompertz P,
Ebrahim S. 1998 [57]
A patient-centred study of the
consequences of stroke.
UK As above As above
4 Wyller, T.B; Kirkevold, M.
1999 [58]
How does a cerebral stroke
affect quality of life? Towards
an adequate theoretical account.
Norway n =6 Interviewed three years after
stroke. Thematic analysis
4 male, 2 female.
Age: 65-85
5 Pilkington F. 1999 [59] A qualitative study of life
after stroke.
Canada n =13 32 interviews at 3 time points:
during acute stay, 1 month and
3 months after stroke. Longitudinal
descriptive exploratory analysis.
9 male, 4 female
Age: 40-91
6 Secrest J, Thomas S.
1999 [46]
Continuity and discontinuity: the
quality of life following stroke.
US n =14 Interviewed between nine months
and 23 years after stroke. Existential
phenomenological methodology.7 male, 7 female
Age: 40-93
7 Ellis-Hill CS, Payne S,
Ward C. 2000 [51]
Self-body split: Issues of identity
in physical recovery following
a stroke.
UK n =8 Life narrative approach, interviews
during hospital stay, 6 months and
one year post-discharge. Twenty four
interviews in total.
5 male, 3 female
Age: 56-82
8 Bendz M. 2000 [53] Rules of relevance after a stroke Sweden n =10 Interviews three to four months
after incident. Medical records
also analysed. Discourse analysis.6 male, 4 female
Age: 58-65
1st time stroke survivors
9 Dowswell GP, Lawler JP,
Dowswell TP, Young JF,
Forster AP, Hearn JP.
2000 [60]
Investigating recovery from
stroke: A qualitative study.
UK n =30 Interviews after an RCT, 13–16
months post-stroke. Thematic analysis.
stroke patients
15 caregivers
10 Burton CR. 2000 [39] Living with stroke: A
phenomenological study.
UK n =6 Tracked for 12 months after stroke.
73 interviews in total. Phenomenology
and grounded theory methods.2 male, 4 female
Age: 52-81
11 Eaves YD. 2000 [50] ‘What happened to me’:
Rural African American elders’
experiences of stroke
US n =8 Descriptive narrative analysis.
2 male, 6 female
Age: 56-79
African American elders
10 care-givers
12 O’Connell B, Hanna B,
Penney W, Pearce J,
Owen M, Warelow P.
2001 [38]
Recovery after stroke:
A qualitative perspective.
Australia Stroke survivors Five focus groups, three with stroke
survivors, 2–180 months after stroke,
one with carers, and one with key
informants. Total of 40 participants.
Content analysis
Age: 20-89
Carers and key informants
13 Kirkevold M. 2002 [61] The unfolding illness trajectory
of stroke.
Norway n =9 63 interviews. First interview 1–2
weeks after onset. Prospective and
longitudinal case studiesmild to moderately
affected stroke patients
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Table 3 Summary of qualitative studies (Continued)
14 Hilton E. 2002 [54] The meaning of stroke in elderly
women: a phenomenological
investigation.
US n =5 Interviewed twice in non-institutionalised
settings at least 1 year post-stroke.
Hermeneutic phenomenology.Elderly women
Age: 66–80 years
15 Gubrium JF, Rittman MR,
Williams C, Young ME,
Boylstein CA. 2003 [62]
Benchmarking as everyday
functional assessment in stroke
recovery.
US Male stroke survivors
of various ages and
from three ethnic
groups (Hispanic,
African American, and
non-Hispanic White)
40 in-depth qualitative interviews
one month following discharge
16 Kvigne K, Kirkevold M.
2003 [41]
Living with bodily strangeness:
Women’s 17experiences of their
changing and unpredictable
body following a stroke.
Norway n =25 Interviewed three times: during
1st 6 weeks, 6 months and one
year post-stroke. Phenomenological
and feminist study.
25 female
Age: 37-78
Women in rural Norway
17 partnered
17 Kvigne K, Kirkevold M,
Gjengedal E.2004 [42]
Fighting back - struggling to
continue life and preserve the
self, following a stroke.
Norway As above As above
18 Murray CD, Harrison B.
2004 [44]
The meaning and experience
of being a stroke survivor:
an interpretative
phenomenological
analysis.
UK n =10 5 interviewed, 5 corresponded by
e-mail. Averaged 9 years post-stroke.
Interpretative Phenomenological
Analysis (IPA)
4 male, 6 female
Mean age: 48.8 years
19 Carlsson G, Möller A,
Blomstrand C. 2004 [48]
A qualitative study of the
consequences of ‘hidden
dysfunctions’ one year
after a mild stroke in
persons <75 years.
Sweden n =15 Interviews analysed with grounded
theory
8 male, 7 female
Age: 30-69
Patients with mild
stroke living with
spouse
20 Faircloth CA, Boylstein C,
Rittman M, Gubrium JF.
2005 [52]
Constructing the stroke:
Sudden-onset narratives
of stroke survivors.
US n =111 In-depth interviews. Data collected
at months1, 6, 12, 18 and 24 after
discharge, but only data from 1, 6,
and 12 reported here. Narrative
interpretive method.
Male veterans
Average age: 67
From 3 ethnic groups:
Puerto Rican Hispanic;
African American, and
non-Hispanic White.
21 Clarke P, Black SE.
2005 [55]
Quality of life following
stroke: Negotiating disability,
identity, and resources.
Canada n =8 Interviewed 7 months to 8 years
post stroke. Selected principles
of grounded theory used.3 male, 5 female
Age: 60 and above
Living in a community
dwelling
22 Lobeck M, Thompson AR,
Shankland MC. 2005 [43]
The experience of stroke for
men in retirement transition.
UK n =7 Interviewed more than 6 months
post-stroke. Interpretative
Phenomenological Analysis.7 male
Age: 64-70
From a working class
background.
23 Stone SD. 2005 [56] Reactions to invisible disability:
The experiences of young
women survivors of
hemorrhagic stroke.
Canada n =22 Open ended in-depth interviews.
Constant comparison method.
22 female
Age: 8–49 at the time
of stroke
Age: 19–57 at the time
of interview
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Table 3 Summary of qualitative studies (Continued)
From four different countries:
Scotland, England, U.S. and
Canada, majority Caucasian
24 Olofsson A, Andersson SO,
Carlberg B. 2005 [63]
‘If only I manage to get home
I’ll get better’-Interviews
with stroke patients after
emergency stay in hospital
on their experiences and needs.
Sweden n =9 Interviews with patients with
experience of stroke approximately
4 months previously. Thematic
analysis.
Age: 64-83
25 Alaszewski A, Alaszewski H,
Potter J. 2006 [37]
Risk, uncertainty and life
threatening trauma:
Analysing stroke survivor’s
accounts of life after stroke.
UK n =31 Interviews with survivor or carer in
individual interviews or in focus
groups. Analysis based on grounded
theory.
Age: 38-89
26 Boylstein C, Rittman M,
Hinojosa R. 2007 [47]
Metaphor shifts in stroke
recovery.
US n =49 War veterans from Florida and
Puerto Rico. In-depth interviews
at month 1 and 6 post stroke.
Grounded theory
49 male
27 Jones F, Mandy A,
Partridge C. 2008 [40]
Reasons for recovery after stroke:
A perspective based on personal
experience. Disability and
Rehabilitation.
UK n =10 Interviewed between 6 weeks and
13 months after onset.
Phenomenological approach6 male, 4 female
Mean age: 61.8
28 Popovich JM, Fox PG,
Bandagi R. [64]
Coping with stroke: Psychological
and social dimensions in U.S.
Patients.
US n =60 Interviewed within the first two weeks
after their stroke. Thematic analysis.
Age: 51-89
Ethnicity: Black
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explained by variations in stroke severity. Of the three
studies that utilised the mRS to inform the descriptions for
levels of stroke severity [14,33,35]], two [33,35] provided
descriptors for mild, moderate and severe/major stroke
with categories common to both including: paralysis,
dependence, feeling weakness, numbness or tingling,
mobility and ambulation, expressive problems, memory
and thinking, and facial droop. However, coordination and
dexterity, and returning to normal activities, were only
included in one study [33], and toileting only included
in one other study [35]. Furthermore, mild/minor
stroke was defined by different levels of mRS across studies
(mRS = 1 [35], mRS =1-2 [33] and mRS =2-3 [14]).
Twenty nine coded categories were identified in the
qualitative literature (Table 5). Counts of studies including
each category showed that change in self identity and
social role was the most frequently cited category (n = 26,
93%), followed by emotional difficulties (n = 25, 89%),
mobility and ambulation (n = 24, 86%), and returning to
normal regular activities (n = 24, 86%). The following are
two examples of data from qualitative literature coded
under ‘Change in self-identity, social role’:
TBW “Are you thinking about the fact that you had a
stroke when you say you have changed, or are you
thinking more in general?”
R “No, since I had the stroke. I don’t recognize myself.
It is awful. You are in a way degraded. I am, eventhough you cannot see anything on me. Everybody says
that I’m so not and so on. There’s no help in that.
Nobody realizes how I am in reality.” (Case 4) [58]
In another example loss of physical function leads a
patient to struggle with his sense of who he is in conjunc-
tion with his prestroke identity, as he recounts here:
“The one thing that’s very difficult for me as a
person. . . I cannot relate, or quickly relate, back
to where I was before I had the stroke. So, that
comparison, I just can’t get it through my head to
let that go, that I can’t do that.” (Mr. H. N.) [55]
Comparison of health state descriptions and patients’
experience: thematic synthesis
Mapping categories onto domains related to HRQOL for
both study types resulted in four domains and associated
thematic content (Table 6): biophysical (including 11
categories), mood and cognition (six categories), prognosis
(four categories), and social (eight categories).
Qualitative studies included a wider range of categories
in every domain than health state descriptions. Health
state descriptions missed categories in every domain that
were relevant to patients’ experience, although all categor-
ies included in the health state descriptions were identified
as important to patients in the qualitative studies . In each
domain, the most often cited category differed between
health state descriptions and qualitative studies and, with
the exception of the biophysical domain, the most often
Table 4 Categories included in health state descriptions
Author Solomon et al. [24] Gage et al. [33] Hallan et al. [14] Slot & Berge [35] Shin et al. [34] Robinson et al. [13] Samsa et al. [17]
Year 1994 1996 1999 2009 1997 2001 1998
Stroke severity Mild/moderate severe Mild/moderate/major Minor/major Mild/moderate/severe Minor/major Mild/severe Major
Categories
Paralysis x x x x x x x
Dependence x x x x x x x
Feeling weakness- numbness, tingling x x x x x x
Mobility and ambulation x x x x x
Expressive problems x x x x x x
Coordination & dexterity x x x x
Memory/thinking x x x x
Returning to normal activities x x x x
Facial droop x x x
Toileting x x
Care arrangements x x
Mortality x x
Pain x
Receptive problems x
Continuing or worsening disability x
Number of categories 13 9 9 8 6 5 4
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Table 5 Rank ordering of categories by counts of study and study type
Preference elicitation studies (n = 7) Counts, (%) Qualitative literature (n = 28) Counts, (%)
Paralysis 7 (100) Change in self-identity, social role 26 (93)
Dependence i.e. feeding, dressing, washing 7 (100) Emotional difficulties 25 (89)
Feeling weakness. numbness, tingling 6 (86) Mobility and ambulation 24 (86)
Expressive problems 6 (86) Returning to normal regular activities 24 (86)
Mobility and ambulation 5 (71) Support and networks 23(82)
Coordination and dexterity 4 (57) Coordination and dexterity 23 (82)
Memory and thinking 4 (57) Recovery, getting better 22 (79)
Returning to normal regular activities 4 (57) Dependence i.e. feeding, dressing, washing 20 (71)
Facial droop 3 (43) Expressive problems 17 (61)
Toileting 2 (29) Fatigue 16 (57)
Discharge from care and care arrangements 2 (29) Perception by others 15 (54)
Mortality 2 (29) Unpredictability, unreliability 14 (50)
Pain 1 (14) Paralysis 14 (50)
Receptive problems 1 (14) Concern for NOK 14 (50)
Continuing or worsening disability 1 (14) Memory and thinking 13 (46)
Dizzy and faint 0 (0) Discharge from care and care arrangements 13 (46)
Sight 0 (0) Continuing or worsening disability 12 (43)
Fatigue 0 (0) Perplexity 11 (39)
Mind-body split 0 (0) Further risk 11 (39)
Loss of swallow 0 (0) Feeling weakness. numbness, tingling 11 (39)
Concern for NOK 0 (0) Mortality 11 (39)
Change in self-identity, social role 0 (0) Dissociation of self and body 9 (32)
Unpredictability, unreliability 0 (0) Dizzy and faint 6 (21)
Perplexity 0 (0) Pain 6 (21)
Perception by others 0 (0) Sight 6 (21)
Support and networks 0 (0) Toileting 4 (14)
Emotional difficulties 0 (0) Facial droop 3 (11)
Further risk 0 (0) Loss of swallow 3 (11)
Recovery, getting better 0 (0) Receptive problems 2 (7)
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culties; recovery, getting better; change in self-identity) did
not appear at all in the health state descriptions.
A key feature of patients’ experience of stroke was
the unanticipated, and therefore disruptive and some-
times shocking, nature of the experience. This carried
through into the recovery phase, not only in the form
of uncertainty about long term survival, but also in
the potential for the disruption of everyday life. Cat-
egories in the biophysical domain reflect this potential
disruption. Within this domain, paralysis was cited
most often in the descriptions, in contrast to mobility
and ambulation in the qualitative studies. Furthermore,
dizziness and fainting, effects on sight, loss of swallow and
fatigue, that were prominent in the qualitative literature,
were absent from health state descriptions. Most notably,
fatigue was cited in over half of the qualitative studies andthe following are two examples of text coded under this
category:
“Such a small and simple thing that you used to do in
no time at all without even thinking, you, well, you
now have to put all your energy into it… and also
when you have to carry something in, you sort of feel
how useless it is (I, male 59 years, married)” [53]
“This feeling of fatigue, it comes as quick as a bolt of
lightning. I don’t feel any signals, and all of a sudden
I’m totally exhausted. I should have a timer that
tickled me every hour, so I know that I should stop and
take a rest” [48]
Within the mood and cognition domain, emotional
difficulties, dissociation of self and body, and perplexity
Table 6 Domains and categories by counts of study and study type
Domains Preference elicitation studies (n = 7), (%) Qualitative literature (n = 28), (%)
Biophysical features
Mobility and ambulation 5 (71) 24 (86)
Coordination and dexterity 4 (57) 23 (82)
Fatigue 0 (0) 16 (57)
Paralysis 7 (100) 14 (50)
Feeling weakness- numbness, tingling 6 (86) 11 (39)
Dizzy/faint 0 (0) 6 (21)
Pain 1(14) 6 (21)
Sight 0 (0) 6 (21)
Toileting 2 (29) 4 (14)
Facial droop 3 (43) 3 (11)
Loss of swallow 0 (0) 3 (11)
Mood and cognition
Emotional difficulties 0 (0) 25 (89)
Expressive problems 6 (86) 17 (61)
Memory/thinking 4 (57) 13 (46)
Perplexity 0 (0) 11 (39)
Dissociation of self and body 0 (0) 9 (32)
Receptive problems 1 (14) 2 (7)
Prognosis
Getting better 0 (0) 22 (79)
Continuing or worsening disability 1 (14) 12 (43)
Further risk 0 (0) 11 (39)
Mortality 2 (29) 11 (39)
Social features
Change in self-identity, social role 0 (0) 26 (93)
Returning to normal activities 4 (57) 24 (86)
Support and networks 0 (0) 23 (82)
Dependence i.e. feeding, dressing, washing 7 (100) 20 (71)
Perception by others 0 (0) 15 (54)
Unpredictability, unreliability 0 (0) 14 (50)
Concern for NOK 0 (0) 14 (50)
Discharge from care and care arrangements 2 (29) 13 (46)
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their prominence in the patient perspective. In particular,
emotion was the most cited category from qualitative
studies, and one of the most cited categories overall in the
qualitative literature, whereas expressive problems were
most often cited in the health state descriptions. Examples
of text coded under ‘emotion’:
“I thought that it could not be true! I felt desperate
because of what had happened. I thought that it could
not be true, so I tried to walk, but I couldn’t. . . . I
became very depressed and cried a lot.” [42]Overall, an alphabet of feelings was mentioned: angry,
ashamed, bewildered, burdensome, depressed, frustrated,
helpless, inadequate, imperfect, shocked, suicidal, surprised,
tearful, tetchy, traumatized, vulnerable, worried:
“ this is why I’m so frustrated - everything I do, I’m so
slow to what I used to be.” [60]
Within the prognosis domain, concerns about recovery
and further risk were prominent in the patient perspective
but missing from the health state descriptions. In addition, a
wider range of categories relevant to patient experience in
Gray et al. BMC Health Services Research 2014, 14:573 Page 12 of 15
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than any other domain. These included unpredictability and
unreliability, concern for next of kin, perception by others,
support and networks, and changes in self-identity and
social role; the last two were cited most often in qualitative
studies, whereas dependence was dominant in the health
state descriptions.
Discussion
To our knowledge, this is the first study to explore the
extent to which stroke health state descriptions used in
preference elicitation studies reflect patients’ experience,
by reviewing and comparing published health state
descriptions used in elicitation studies with a qualitative
synthesis of stroke patients’ perspectives on what is
important to them. Variation exists in the content of
health state descriptions for all levels of stroke severity.
Of greater concern is the major disjuncture between how
stroke is experienced by patients and the representation
of stroke in the health state descriptions, which appears
to reflect an absence of engagement of stroke patient
perspectives in their development. This raises significant
concerns about the validity of the descriptions and hence
the values derived from them, and about the methods used
to develop health state descriptions. This has potentially
significant consequences for the use of the values elicited
using such descriptions in health policy and clinical/patient
decisions.
There are some study limitations. Despite covering a range
of different strokes and stroke severities [24,48,55,60,61,63],
the available accounts tend to exclude the perspectives of
those with more severe strokes, particularly involving speech
impairments [48]. Nonetheless, our review included a wide
range of studies and patient groups. In order to indicate the
spread of categories across the data sources, we counted the
number of data sources (published qualitative studies and
health state descriptions) in which these categories appear.
This is an indirect measure of importance to patients, but
nonetheless captures the presence of key categories across a
range of studies exploring patient experience. An inherent
limitation of content analysis is that counts of content cannot
in itself produce a deep understanding of the data, but to
ameliorate this we also conducted and report a thematic
synthesis.
Previous research regarding the impact of the measure-
ment process on utility values exists. Specifically for stroke,
variations in estimates resulting from direct preference
elicitation have previously been explained by a number of
factors. First, the choice of study population; for example,
healthy participants assign lower utilities than patients who
have experienced stroke [11,17]. Second, the method
of elicitation, with standard gamble derived scores being
generally higher than those derived from time trade off
studies, which in turn are higher than those derived fromvisual analogue scales [16,18]. Third, the bounds of the
scale, typically 0–1, may be defined differently: the upper
bound defined as perfect health yields lower utility scores
than if defined as the absence of the condition of interest,
which is no guarantee that health is perfect [19].
Variations in health state description content may
also explain differences. The level of detail in health
state descriptions can affect utility scores; longer,
more comprehensive, descriptions (although appearing
to have more face validity), may overload respondents’
cognitive capacity, so that they latch onto a few key
phrases and ignore the rest [20]. Naming or labelling
a condition may have an impact [10,12,21-23] with a recent
study recommending avoiding condition labels in health
state descriptions to ensure that values are not affected by
prior knowledge or preconceptions of the condition that
may distort the health state being valued [10]. Furthermore,
the wording may also cause variation in values if not pre-
sented in a balanced manner (framing bias), with both
positive and negative effects described; explicit inclusion
of negative aspects of stroke elicit lower values [24,25].
A key element in developing valid health state descrip-
tions is whether the description accurately reflects
patient experience. However, there is little empirical
work on the content validity of health state descriptions,
nor on the methods of their development, despite long
standing arguments for this [22,66]; this may explain
significant variations or biases in utility scores [67]. This
failure to take account of patient experience is the most
probable explanation for the observed variation in stroke
health state descriptions, and most importantly for the
disjuncture between them and what is important to
patients. At a population level, variations or biases in
utility scores may have serious implications for resource
allocation decisions within health care systems. For
example, NICE recommends the use of Quality Adjusted
Life Years (QALYs) as a measure of health benefit for their
‘reference case’, to enable a standardized approach for
comparing economic evaluations across different healthcare
areas [1]. Indirect preference elicitation using the EQ-5D is
the method and measure of HRQOL in adults that is pre-
ferred by NICE decisions taken at a national level. Despite
this, a review of the selection and use of health-related util-
ity values for economic models included in NICE
Technology Appraisals [68] found that only 56% of
submissions to NICE and assessment reports included
utility values that met the relevant reference case. This
highlights variation in the methods used to select and
incorporate utility values in economic models for NICE
Technology Appraisals. Furthermore, methods for guideline
production in other countries are in general less prescrip-
tive regarding methods of preference elicitation [69], thus
being more likely to incorporate direct methods of prefer-
ence elicitation. The use of direct preference elicitation
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validity could have an impact on the estimated cost effect-
iveness of health interventions and associated resource
allocation decisions.
Health state descriptions were commonly derived from
the Modified Rankin Scale (mRS), a clinician-derived
measure of global disability [70], but the content of these
descriptions differed across studies. Descriptions in
other studies were either derived directly from clinicians
or their derivation was not described. Most critically,
none of the preference elicitation studies utilised stroke
patients’ perspectives to inform the content of the
descriptions, in stark contrast to the standard methods
of developing HRQOL measures [71], where the extent
to which patient experience has generated the content
and domains is a critical indicator of validity [18,19].
These findings are disturbing - nearly two decades
ago it was recommended that health state description
development should draw upon a range of perspectives,
by collating information on health states by using the
evidence base, and/or interviewing medical professionals
and patients, in order to seek a consensus on the most
important aspects of quality of life and their relative
importance [72]. Similarly, the importance of incorporating
patients’ perspectives to establish domain and content
validity of the impact of stroke on QOL using qualitative
research, either by asking patients directly or by using the
evidence base has also been recognised [9]. Despite these
recommendations, none of the preference elicitation studies
for stroke used these methods.
Given this absence of the patient perspective, the
disjuncture between how stroke is experienced and the
representation of stroke in the health state descriptions is
not surprising. As detailed in the results above, for
example, the qualitative studies demonstrate that unrespon-
sive or unpredictably responsive limbs, fatigue, cognitive
difficulties and emotional ability led those recovering from
stroke to curtail their activities, resulting for many in lives
that little resembled their pre-stroke existence. This con-
trasts with the lack of emphasis on these features in health
state descriptions. Furthermore, the effects of stroke on
everyday life had significant implications for social role,
identity and relationships. No longer able or confident
in their ability to engage in everyday activities, the
relationships associated with these activities shifted.
Stroke survivors often disengaged from, or restricted,
their social networks, leading to social isolation. Social
relationships were disrupted, via dependence on others,
resulting from the physical and emotional effects of
stroke. These social characteristics were noticeably absent
from the health state descriptions.
Whilst direct methods of preference elicitation have an
important role to play, the content validity of health state
descriptions for stroke, as with HRQOL instruments, canonly be established if patients’ perspectives on the impact of
the health state are incorporated into their development.
The fact that patients’ experiences of stroke incorporate a
much wider set of categories than those incorporated in the
health state descriptions, emphasises the importance of this.
Conclusions
Key features of the methodological process for directly
eliciting utility values for stroke can explain variations in
estimates. One such feature is the design and content of
health state descriptions. Our findings not only show that
there is no systematic method for constructing the content/
scope of health state descriptions for stroke, but also critic-
ally that the perspective of patients is not incorporated. We
have demonstrated that this produces descriptions with
major deficits in reflecting the lived experience of stroke,
and raises serious questions about the values derived
from such descriptions, which might lead to erroneous
conclusions in decisions made based on these values.
We recommend that health state descriptions used for
direct preference elicitation, as with HRQOL instruments,
should be developed with reference to patient perspectives
derived from published qualitative research and/or
directly from patients themselves. Further research into
the differing impact of descriptions that do or do not
incorporate what is important to patients would help to
characterise the impact of these deficits in terms of utility
scores and associated Quality Adjusted Life Years (QALYs)
and resource allocation decisions.
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